Safety Study of Tezepelumab (AMG 157) in Healthy Adults
NCT00972179 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 49
Last updated 2022-09-21
Summary
The primary objective is to evaluate the safety, tolerability, and immunogenicity of multiple-dose administration of tezepelumab in healthy adults.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
Administered by subcutaneous or intravenous injection.
- DRUG
-
Tezepelumab
Administered by subcutaneous or intravenous injection
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
MD · Amgen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-09-15
- Primary Completion
- 2011-01-09
- Completion
- 2011-01-09
More Related Trials
-
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
NCT06544499 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of AMG 531 in Japanese Subjects With ITP
NCT00305435 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
NCT01727232 ·Status: COMPLETED
-
High-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial
NCT05943691 ·Status: UNKNOWN ·Phase: PHASE2
-
Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
NCT00117143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
NCT03102593 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
NCT07286032 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
NCT04200456 ·Status: TERMINATED ·Phase: PHASE3
-
The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment
NCT03673215 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
NCT00039910 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients
NCT03866577 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia
NCT06199089 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
NCT02868099 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia
NCT02857530 ·Status: UNKNOWN ·Phase: PHASE2
-
AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy
NCT00102336 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)
NCT01566695 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Romiplostim in Immune Thrombocytopenia (ITP) in the " Real-life " : Result of the French Experience in 72 Adults
NCT01013181 ·Status: COMPLETED
-
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
NCT07065968 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate Safety and Efficacy in Adult Subjects With ITP
NCT02273960 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP
NCT07189910 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia
NCT05325593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers
NCT00612196 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
NCT00515203 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
NCT05678621 ·Status: RECRUITING ·Phase: PHASE2/PHASE3